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Background: The 3β, 6β, 16β-trihydroxylup-20(29)-ene (TTHL) is a pentacyclic triterpene obtained from the
medicinal plant Combretum leprosum Mart. In folk medicine, this plant is popularly known as mofumbo, cipoaba or
mufumbo, and is used to treat several diseases associated with inflammation and pain.
Methods: We investigated the antitumor efficacy of TTHL isolated from C. leprosum. The TTHL cytotoxic effect was
investigated in MRC5, MCF-7, HepG2, T24, HCT116, HT29, and CACO-2 cells after 24, 48, 72 and 120 h of treatment.
The mechanisms of cell death and DNA damage induction were investigated by flow cytometry and comet assay,
respectively.
Results: The results indicated that TTHL induced a time- and concentration-dependent growth inhibition in all
human cancer cell lines. The cytotoxicity was more pronounced in MCF-7 breast cancer cells, with an IC50 of
0.30 μg/mL at 120 h. We therefore evaluated the cell death mechanism induced by TTHL (IC20, IC50, and IC80) in
MCF-7 cells at 24 h. We found that the treatment with IC50 and IC80 TTHL for 24 h induced apoptosis in 14%
(IC50) and 52% (IC80) of MCF-7 cells. The apoptosis induced by TTHL was accompanied by increased levels of both
cleaved caspase-9 and intracellular ROS. In order to further understand the biological mechanism of TTHL-induced
cytotoxicity, we have also investigated its effect on different Saccharomyces cerevisiae yeast strains. The mutant
strains sod1Δ, sod2Δ, and sod1Δsod2Δ, which are deficient in superoxide dismutase antioxidant defenses, were
hypersensitive to TTHL, suggesting that its capacity to disturb cellular redox balance plays a role in drug toxicity.
Moreover, TTHL induced mutagenicity in the yeast strain XV185-14c.
Conclusions: Taken together, the results suggest that TTHL forms covalent adducts with cellular macromolecules,
potentially disrupting cellular function and triggering apoptosis.
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Medicinal plants have been used since ancient times in
virtually all cultures as a source of medicines [1], and
are of great importance to the health of individuals and
communities [2]. Traditional medicine is used in all
parts of the World and has a rapidly growing economic
importance, mainly through the use of medicinal plants,
especially in developing countries [3]. The medicinal use
of plants of the Combretaceae family is widely described
in the scientific literature [4-6]. This family is distributed
in 20 genera, with approximately 600 species. The lar-
gest genera are Combretum and Terminalia, with about
370 and 200 species, respectively [7]. Members of Com-
bretaceae occur mainly in tropical and subtropical areas,
such as Africa and Brazil [8].
In North and Northeastern Brazil, the species Combre-
tum leprosum Mart. is popularly known as mofumbo,
cipoaba or mufumbo. Infusions prepared with the aerial
parts (stems, leaves and flowers) and roots of C. leprosum
are used in folk medicine to heal wounds, to treat
hemorrhages, or as a sedative [9,10]. According to phyto-
chemical analysis, C. leprosum is rich in compounds such
as cycloartanes, triterpenes [arjunolic, mollic acid and
3β,6β,16β-trihydroxy-lup-20(29)-ene (TTHL - Figure 1)],
and flavonoids (3-O-methylquercetin, 5,3′-dihydroxy-
3,7,4′-trimethoxyflavone, 5,3′,4′-trihydroxy-3,7-dimethox-
yflavone, and quercetin), and some of these substances
have proven biological activity [9,11-15].
The pentacyclic triterpene TTHL, obtained from the
flowers of C. leprosum [16], presents a pronounced anti-
nociceptive effect [11], which is dependent on opioid
and serotonergic systems, G(i/o) protein activation and
the opening of specific K(+) channels [11]. BehavioralFigure 1 Chemical structure of TTHL (3β,6β,16β-trihydroxy-lup-20
(29)-ene) isolated product from Combretum leprosum.and electrographic recordings revealed that pretreatment
with TTHL increased the latencies to the first clonic
seizure to the tonic-clonic and reduced the duration of
the generalized seizures induced by the GABA(A) recep-
tor antagonist pentylenetetrazol [17].
Although considerable work has been done on the plant
for different activities, scientific information on toxico-
logical properties of TTHL is still not available. Since
elimination of cancer in early stages is an integral part
of chemoprevention, the assessment of antiproliferative
properties against cancer cells provides useful insights
on the chemo-protective potential of natural products.
In this sense, we evaluated the abilities of TTHL to
function as an antitumoral drug. Moreover, to further
understand the biological mechanism of the cytotoxic
effect of TTHL, our group also investigated its effect on
different Saccharomyces cerevisiae strains.
Methods
Chemicals
Dulbecco’s modified Eagle’s medium (DMEM), low-
melting-point agarose (LMP), high-melting-point agar-
ose (HMP), phosphate-buffered saline (PBS; Na2HPO4,
KH2PO4 and KCl, pH 7.4), propidium iodide (PI), mitox-
antrone (MXT), hydrogen peroxide (H2O2), amino acids
and nitrogenated bases were purchased from Sigma (St.
Louis, MO, USA). Fetal bovine serum (FBS) and penicil-
lin/streptomycin were obtained from Gibco-BRL (Grand
Island, NY, USA). Primary antibody anti-caspase-9 and
secondary antibody anti-rabbit IgG (H + L) F(ab’)2 frag-
ment conjugated to Alexa Fluor® 488 were obtained from
Cell Signaling Technology (USA) and Invitrogen (Grand
Island, NY, USA), respectively. Cell Proliferation Kit II
(XTT) was acquired from Roche (Basel, Switzerland).
Annexin V-Phycoerythrin (PE) and 7-Amino-Actinomycin
(7-AAD) were purchased from BD Biosciences (San Diego,
CA). Yeast extract, bacto-peptone, bacto-agar and yeast
nitrogen base were obtained from Difco Laboratories
(Detroit, MI). All other reagents were of analytical grade.
Plant material and TTHL isolation
Botanical material was collected by Dr. Edilberto Rocha
Silveira (Federal University of Ceará, Fortaleza) in May
2007 in a free area of Viçosa, Ceará State, Brazil, and
classified by Dr. Afrânio Fernandes (Federal University
of Ceará, Fortaleza) as Combretum leprosum Mart. A vou-
cher specimen of this plant was deposited in Herbarium
Prisco Bezerra of the Biology Department, Federal Univer-
sity of Ceará, Brazil, under number 12446. All necessary
permits were obtained for the harvesting of the flowers.
The isolation of TTHL triterpene has been described
by Facundo et al. [16]. Briefly, the dried flowers (2.7 kg)
were powdered and extracted with ethanol (5 L), being
stirred and macerated at room temperature (24 ± 3°C)
Viau et al. BMC Complementary and Alternative Medicine 2014, 14:280 Page 3 of 12
http://www.biomedcentral.com/1472-6882/14/280for approximately 24 h. This procedure was repeated
three times. The solvent was fully evaporated under re-
duced pressure and the EE (yield 58.3 g) was lyophilized
and stored in a freezer at −20°C until use. Part of the EE
(32.0 g) was subjected to column chromatography on sil-
ica gel, eluting with n-hexane, chloroform (CHCl3), ethyl
acetate (EtOAc) and methanol (MeOH). The fraction
eluted with CHCl3 was chromatographed on a silica gel
column and was eluted with n-hexane-EtOAc, in in-
creasing polarity. The fractions 27–30, eluted with n-
hexane-EtOAc (30:70), were combined on the basis of
thin layer chromatography (TLC) analysis, and the pres-
ence of a white precipitate was observed, which after
recrystallization from ethanol was identified as TTHL
(2.37 g). The analysis of 1H NMR and 13C NMR spectra
showed that TTHL analytical and spectroscopic data
fully agreed with their assigned structures [16], and the
chemical purity of TTHL was > 98% [11,12]. For cell
treatments, a stock solution of the TTHL was prepared
freshly prior to use, using dimethylsulfoxide (DMSO) as
solvent. The appropriate concentrations were obtained
by diluting the stock solution in sterile distilled water,
and the final concentration of DMSO in the incubation
mixture never exceeded 0.1%. Control samples were al-
ways treated with the same amount of DMSO (0.1% v/v)
as used in the corresponding experiments.
Assays with mammalian cells
Culture conditions
The human cell lines MCF-7 (breast adenocarcinoma),
HepG2 (hepatoma), T24 (bladder cancer), CACO-2
(colorectal adenocarcinoma) and MRC5 (lung normal
fibroblast) were obtained from the Rio de Janeiro Cell
Bank (Rio de Janeiro, RJ, Brazil). The HCT116 cell (colo-
rectal carcinoma), and HT29 cell (colorectal adenocar-
cinoma) were kindly provided by Dr. Annette K. Larsen
(Institut National de la Santé et de la Recherche Médicale -
INSERM, Paris, França). All cell lines except MCF-7 were
grown in DMEM supplemented with 10% or 20% (for
CACO-2) FBS, 100 units.mL−1 penicillin and 100 μg.mL−1
streptomycin at 37°C in a humidified atmosphere of 5%
CO2. MCF-7 cells were maintained in RPMI-1640 supple-
mented with 20% FBS at the same conditions described
above.
Cell viability assay
The cytotoxic potential of the TTHL was evaluated by
the XTT assay in human tumor cell lines as well as in
MRC5 normal fibroblasts. Cells (1 × 104 cells) were
seeded on 96-well plates in growth medium and incu-
bated overnight. Afterwards, TTHL (0.5, 1.0, 2.5, 5.0,
and 10 μg/mL) was added to each well and incubated
for 24, 48, 72, and 120 h. Mitoxantrone, a cytostatic
anthracenedione that intercalates in DNA and increasesthe incidence of double-strand breaks by stabilizing the
cleavable complex of topoisomerase II and DNA, was
used as positive control [18]. At the end of each treat-
ment, cell viability was assessed according to the ma-
nufacturer’s instructions. Briefly, after discarding the
medium, 1 mL of XTT labeling mixture was added to
the cells and incubated for 2 h at 37°C. Absorbance was
measured with a SpectraMax reader (Bio-Rad, USA) at a
test wavelength of 492 nm (A492) and a reference wave-
length of 690 nm (A690). The final result corresponds to
A492-A690. The absorbance of negative control cells was
set as 100% viability, and the values for treated cells were
calculated as a percentage of the control.
All other experiments (comet, cell cycle, apoptosis, ROS
production and protein expression assays) were conducted
in the breast cancer cell line MCF-7 using IC20 = 0.50 μg/
mL (20% inhibitory concentration), IC50 = 1.36 μg/mL (50%
inhibitory concentration) and IC80 = 3.70 μg/mL (80% in-
hibitory concentration) values of TTHL, as determined by
XTT assay. Cells (2 × 105 cells/mL) were seeded on 6-well
tissue culture plates, and grown for 1 day up to 70–80%
confluence before treatment with the test substance. The
TTHL was added to medium with FBS to obtain the dif-
ferent concentrations, and cells were treated at 37°C for
24 h in humidified atmosphere containing 5% CO2.
Cell cycle distribution by flow cytometric analysis
Cell cycle distribution determination analysis was per-
formed as previously described [19]. After treatment,
cells were trypsinized, centrifuged and resuspended in
ice-cold 70% ethanol, and left for 24 h at 4°C. Ethanol-
fixed cells were centrifuged, washed with PBS and resus-
pended in buffer containing 0.2 mg/mL RNAse, 50 μg/
mL PI and 0.1% Triton X-100, and incubated for 30 min
at room temperature. Samples were analyzed on a FACS
Calibur flow cytometer (Becton-Dikinson, San Fransisco,
CA) using the CellQuest software. A total of 10,000
events were measured per sample. The data were ana-
lyzed to determine the percentage of cells at each phase
of the cell cycle (sub-G1, G1, S and G2/M).
Assessment of apoptosis by flow cytometric analysis
Annexin V-PE was used in conjunction with a vital dye,
7-AAD, to distinguish apoptotic (Annexin V-PE positive,
7-AAD negative) from necrotic (Annexin V-PE positive,
7-AAD positive) cells. After treatment, cells were trypsi-
nized, collected and resuspended in 40 μL of binding buf-
fer with 2 μL Annexin V-PE. Cells were incubated for
15 min in the dark at room temperature. After incubation,
160 μL of binding buffer and 2 μL of 7-AAD were added.
Cells were incubated for 5 min and additional 200 μL of
binding buffer were added. Before analysis, cells were fil-
tered through a cell strainer cap fitted to a polystyrene
round bottom flow cytometric tube. Data were collected
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CellQuest software, in a total of 10,000 events per sam-
ple; fluorescence was measured and the percentage of
viable, early apoptotic, late apoptotic and necrotic cells
was determined.
Quantification of cleaved caspase-9 by flow cytometric
analysis
After treatment, cells (1 × 106) were harvested, resus-
pended in 25 μL PBS and fixed with 4% formaldehyde.
After permeabilization and blocking (0.2% Triton X-100
in PBS and 1% BSA), cells were incubated with anti-
caspase-9 antibody (diluted 1:1000) for 1 h at room
temperature, followed by incubation with anti-rabbit
FITC secondary antibody (Uniscience) (diluted 1:1000)
for 1 h at room temperature in the dark. A total of
10,000 events were analyzed per sample by FACS Cali-
bur flow cytometer. Fluorescence intensity in arbitrary
units was plotted in histograms; the mean fluorescence
intensity was calculated using CellQuest software.
Alkaline comet assay
The alkaline comet assay was performed as previously
described [20]. Briefly, 10 μL of cell suspension (1 × 104
cells) treated with TTHL were mixed with 90 μL LMP
agarose, spread on a normal agarose precoated micro-
scope slide, and placed at 4°C for 5 min to allow for solidi-
fication. Cells were lysed in high concentration of salt and
detergent (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris
with 1% Triton X-100 and 10% DMSO freshly added) for
2 h. Slides were removed from lysing solution and washed
three times with PBS. Subsequently, cells were exposed to
alkali conditions (300 mM NaOH/1 mM Na2EDTA, pH
>13, 30 min, 4°C) to allow DNA unwinding and expres-
sion of alkali-labile sites. Electrophoresis was conducted
for 25 min at 25 V and 300 mA (94 V/cm). After electro-
phoresis, the slides were neutralized and silver stained
[21]. One hundred cells were scored visually according to
the tail length and the amount of DNA present in the tail.
Each comet was given an arbitrary value of 0–4 (0, un-
damaged; 4, maximally damaged), as described by Collins
et al. [22]. Damage score was thus assigned to each sam-
ple and can range from 0 (completely undamaged: 100
cells × 0) to 400 (with maximum damage: 100 cells × 4).
International guidelines and recommendations for the
comet assay consider that visual scoring of comets is a
well-validated evaluation method, as it is highly correlated
with computer-based image analysis [22,23].
Reactive oxygen species (ROS) detection by flow
cytometric analysis
Levels of intracellular ROS were estimated following treat-
ment with TTHL using 2′,7′-dichlorofluorescein diacetate
(H2DCFDA, Sigma) as a fluorescent probe. Detection ofoxidative stress was done by incubating the cells with
20 μM of H2DCFDA for 20 min at 37°C. Cells were then
detached by trypsinization and washed twice with PBS.
After filtration through cell strainer cap, cells were ana-
lyzed using a FACS Calibur flow cytometer with CellQuest
software in accordance with Bass et al. [24]. A total of
10,000 events were measured per sample. DCF fluores-
cence intensity was shown in arbitrary units.
Assays with S. cerevisiae
Strains, media and treatment
The relevant genotypes of yeast strains used in this work
are shown in Table 1. Media, solutions and buffers were
prepared according to Burke et al. [25]. YPD medium
(0.5% yeast extract, 2% peptone, 2% glucose) was used
for routine growth. Synthetic medium SC (0.67% yeast
nitrogen base, 0.1% ammonium sulfate, 2% glucose) sup-
plemented with the appropriate amino acids and bases
(40 mg/mL) was used for the detection of mutations.
Stationary phase (STAT) cultures were obtained by in-
oculation of a single colony into liquid YPD. We chose
to work in the stationary phase of growth because this
resembles most cells of multicellular organisms in im-
portant aspects: (i) most energy comes from mitochon-
drial respiration; (ii) the cells have left the active cell
cycle and have entered the Go phase; and (iii) damage
accumulates over time [26,27].
Survival assays in the EG103 background strains
STAT cells (1 × 108 cells/mL) were exposed to TTHL (10–
500 μg/mL) and incubated under growth conditions for 1 h
in PBS at 30°C. Cells were then washed and treated with
H2O2 (5 mM) in PBS for another hour. Suitable aliquots
were plated in triplicate on solid YPD (2–3 days, 30°C) and
colony-forming units were counted. Sensitivity was
expressed as a percentage of survival in relation to the
negative control (solvent) [28].
Point and frameshift mutations in the XV185-14c haploid
yeast
Cell cultures were grown as described above, exposed to
TTHL in concentrations ranging from 10 to 500 μg/mL,
and then incubated in PBS for 1 h at 30°C. Two alleles,
his1-798 and lys1-1, were used to detect point muta-
genesis. The suppressible ochre nonsense mutant allele
lys1-1 can be reverted either by locus-specific sequence
alteration (true reversion) or by a forward mutation in a
suppressor gene. Distinction between true reversions
and forward (suppressor) mutations at the lys1-1 locus
was performed according to Schuller & Von Borstel
[29], where the reduced adenine content of the SC-lys
medium shows true reversions as red and suppressor mu-
tations as white colonies. Survival was determined on SC
medium (3–5 days, 30°C) and mutation induction (HIS,
Table 1 Saccharomyces cerevisiae strains used in this study
Strain Genotype Enzymatic defense lacking Source
EG103 (SOD-WT) MATα: leu2Δ0 his 3-Δ1 trp1-289 ura 3-52 None E. Grallaa
EG118 (sod1Δ) Like EG103, except sod1::URA3 Cu-Zn SOD (cytosolic) E. Grallaa
EG110 (sod2Δ) Like EG103, except sod2::TRP1 Mn SOD (Mitochondrial) E. Grallaa
EG133 (sod1Δsod2Δ) Like EG103, except sod1::URA3 and sod2::TRP1 Without SOD E. Grallaa
XV185-14c (WT) MATα: ade2-2 his1-798 lys1-1 trp5-48 hom3-10 arg4-17 None von Borstel et al. (1971)b
aDepartment of Chemistry and Biochemistry, University of California, Los Angeles 90024–1569, USA. bVon Borstel RC, Cain KT, Steinberg CM (1971) Inheritance of
spontaneous mutability in yeast. Genetics 69:17–27.
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priate amino acid (7–10 days, 30°C). Induction of rever-
sion of point mutation to his1-798, ochre allele lys1-1,
and frameshift mutation values were scored per number
of surviving cells.
Statistical analysis
The IC20, IC50, and IC80 values and their 95% confi-
dence intervals (CI 95%) were obtained by nonlinear re-
gression using GraphPad Prism v5 program (Intuitive
Software for Science, San Diego, CA, USA). Selective
index (SI) was calculated by IC50 in MRC5 cells/IC50 in
tumoral cells. All experiments were independently re-
peated at least three times, with triplicate samples for
each treatment. Results are expressed as means ± stand-
ard deviation (SD). Data were analyzed by one-way ana-
lysis of variance (ANOVA), and means were compared
using Tukey test, with P ≤ 0.05 considered as statistically
significant.
Results
Effects of TTHL on tumoral cells
Table 2 shows the cytotoxic effects of TTHL on cell
lines. The antiproliferative effects were quantified in
terms of IC50 values. The lower the IC50 value, the
higher the antiproliferative activity. TTHL induced
concentration-dependent cytotoxic effects in all the ex-
amined cell lines after 24, 48, 72 and 120 h. The ratio
between the cytotoxic parameters found in MRC5 cells






24 8.40 ± 0.28 1.36 ± 0.056X 6.50 ± 0.431.3X
48 7.60 ± 0.14 0.73 ± 0.0510X 6.10 ± 0.281X
72 7.40 ± 0.15 0.63 ± 0.0412X 5.45 ± 0.351X
120 6.84 ± 0.10 0.30 ± 0.0423X 0.88 ± 0.138X
24/MXTc 2.88 ± 1.44 0.87 ± 1.59 3.5 ± 0.39
aDrug concentration required to inhibit the cell growth by 50% after 24 h of incuba
represent mean ± three separate experiments. cMitoxantrone (MXT) was used as poas a measurement of compound selectivity index (SI). SI
ratios between 3 and 6 refer to moderate selectivity, and
ratios higher than six indicate high selectivity, whereas
compounds that do not fulfill either of these criteria are
rated as non-selective [30,31]. The SI value is also shown
in Table 2 (superscript).
Interestingly, our results suggest that TTHL exerted
the highest cytotoxicity against MCF-7 cells, with an
IC50 value of 1.36 ± 0.05 after 24 h of treatment and a
higher potency - six fold more potent in these cells than
in normal cells (MRC5). In addition, TTHL also showed
a significant inhibitory activity in human cancer cell line
T24, but only after 72 h of treatment (Table 2). Com-
paratively, mitoxantrone, used in this study as a positive
control, demonstrated IC50 values ranging from 0.61-
3.5 μg/mL in tumor cell lines. Considering both cyto-
toxic parameters and selectivity index, TTHL displayed
the best profile in MCF-7 cells. Therefore, we chose the
MCF-7 cells for further experiments to verify the cyto-
toxic mechanism of TTHL, using concentrations of
0.50 μg/mL, 1.36 μg/mL and 3.70 μg/mL (IC20, IC50
and IC80, respectively).
Cell cycle distribution by flow cytometric analysis
The results showed there was no significant change
in cell cycle progression after treatment with TTHL
(Additional file 1: Figure S8); however, a significant
increase in the sub-G1 population can be observed
(Figure 2). It is important to note that flow cytometry after
PI staining allows cell cycle analysis and, additionally, any50 (μg/mL)a ± SD
ndex (SI)b/superscript value
T24 HCT116 HT29 CACO-2
5.55 ± 0.641.5X 7.05 ± 0.211X 8.00 ± 0.141X 8.55 ± 0.35MR
5.20 ± 0.421.5X 5.87 ± 0.041X 7.00 ± 0.421X 7.90 ± 0.28MR
1.09 ± 0.147X 5.20 ± 0.281X 6.15 ± 0.211X 6.35 ± 0.351X
0.39 ± 0.1017X 4.50 ± 0.291.5X 5.30 ± 0.281X 5.00 ± 0.191X
2.50 ± 0.62 0.61 ± 0.67 0.88 ± 2.33 2.4 ± 1.81
tion. bSelectivity index (in vitro): IC50 in MRC5 cells/IC50 in tumoral cells. Data
sitive control. MR: more resistant in tumoral cells.
Figure 3 TTHL treatment induces apoptosis in MCF-7 cells.
Annexin V assays analyzing in MCF-7 cells treated with IC20, IC50,
and IC80 TTHL. The sum of the percentages of Annexin V and
7-AAD-PE-positive cells was calculated. Three independent
experiments were pooled and analyzed as a combined data set. Results
are expressed as means ± standard deviation (SD). Data were analyzed
by one-way analysis of variance (ANOVA), and means were compared
using Tukey test, with P≤ 0.05 considered as statistically significant.
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diploid peak [19]. The increased number of cells in
sub-G1 phase population appears to be concentration-
dependent (Figure 2), indicating that TTHL may induce
cell death by apoptosis.
Apoptosis by flow cytometric analysis
The morphology of treated MCF-7 cells was analyzed
using annexin V-PE/7-AAD staining and the percentages
of viable, apoptotic and necrotic cells were calculated.
After 24 h of TTHL (IC80) treatment, approximately
55% MCF-7 cells were in early apoptosis (labeled with
annexin V-PE), 15% cells were in late apoptosis (labeled
with both annexin V-PE and 7-AAD), and a remarkable
decrease was observed in the viable cells population (un-
labeled with either annexin-V or 7-AAD) compared with
the untreated control cells (Figure 3, and Additional file
2: Figure S9). The percentage of necrotic cells (labeled
with 7-AAD) was less than 5% for both TTHL treat-
ments (IC50 and IC80), and the dominant cell death
type was apoptosis.
Quantification of cleaved caspase-9 by flow cytometric
analysis
In order to characterize the apoptosis induced in MCF-7
cell line, we evaluated the activation of apoptosis media-
tors by different TTHL concentrations. We analyzed the
cleavage and consequent activation of caspase-9 by flow
cytometry using specific antibodies that recognize only
the intact (inactive) forms of the enzyme. The results,
summarized in Figure 4, indicate that continuous treat-
ment of cells with TTHL concentrations (IC50 and
IC80) leads to increased induction of cleaved caspase-9-
labeled cells. There is a clear difference on the inductionFigure 2 The subdiploid G1 peak from FACS analysis was used
to estimate the apoptotic cell population on MCF-7 cells after
24 hours’ treatment. Sub-G1 populations are seen to appear at
both IC50 and IC80. Statistical analysis was applied for comparing
control non-treated cells with treated cells. Data are expressed as
mean ± SD of three independent experiments.of cleaved caspase-9 when the IC50 and IC80 values are
compare (Figure 4), although the increased induction of
cell death (sub-G1) in treated MCF-7 cells is confirmed
(Figure 2, and Additional file 1: Figure S8). Moreover,
TTHL (at IC20) caused no significant changes in the
levels of cleaved caspase-9 in MCF-7 cells (Figure 4).
These results were consistent with the data from
Annexin V-PE positive FACS analysis; in fact, the treat-
ment with TTHL at IC50 and IC80 induced a stronger
apoptotic effect on MCF-7 cells when compared to IC20
and control (Figures 2, 3 and 4).
Comet assay
The alkaline (pH > 13) comet assay detects DNA strand
breaks and alkali-labile sites. Our results showed thatFigure 4 Flow cytometric analysis of cleaved caspase 9 activity.
MCF-7 cells were treated with TTHL (IC20 = 0.50 μg/mL, IC50 = 1.36 μg/
mL, and IC80 = 3.70 μg/mL), fixed, permeabilized, and stained with
anti-active caspase 9. Results are expressed as means ± standard
deviation (SD). Data were analyzed by one-way analysis of variance
(ANOVA), and means were compared using Tukey test, with P≤ 0.05
considered as statistically significant.
Figure 6 Flow cytometry detection of reactive oxygen species
in MCF-7 cells challenged with TTHL. Cells were treated with
vehicle negative control, IC20 = 0.50 μg/mL, IC50 = 1.36 μg/mL, and
IC80 = 3.70 μg/mL TTHL after 24 hours’s treatment, and 500 μM H2O2.
Mean data for DCF fluorescence. Results are expressed as means ±
standard deviation (SD). Data were analyzed by one-way analysis of
variance (ANOVA), and means were compared using Tukey test, with
P≤ 0.05 considered as statistically significant.
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However, it induces signifcant DNA damage at IC50 and
IC80 (Figure 5). MMS (8.81 μg/mL) was used as positive
control.
Intracellular increase of ROS is responsible for apoptosis
induced by TTHL in MCF-7 cells
Results shown in Figure 6 and Additional file 3: Figure
S10 revealed that TTHL induces an increase in intracel-
lular ROS production (24 h treatment at IC50: 49% in-
crease; 24 h treatment at IC80: 64% increase) in MCF-7
cells, as measured by flow cytometry.
Effects of TTHL on yeast cells
Cytotoxic and mutagenic effects in S. cerevisiae
TTHL exhibited a concentration-dependent cytotoxic ef-
fects in all strains, with more pronounced effect in
double mutant sod1Δsod2Δ (lacks cytoplasmic and mito-
chondrial superoxide dismutase enzymes) (Table 3). The
mutagenesis induction was evaluated and the results
showed that TTHL was cytotoxic in XV185-14c in all
concentrations tested. Notwithstanding, TTHL was only
able to induce mutagenesis on the assessed loci at the
highest concentration (Table 4).
Discussion
Drug discovery from medicinal plants has played an es-
pecially important role in the treatment of cancer and,
indeed, over the last half century, most new clinical ap-
plications of plant secondary metabolites and their deriv-
atives have been applied towards combating cancer [32].
Of all the available anticancer drugs between 1940 and
2002, 40% were natural products or natural product-Figure 5 Effect of TTHL after 24 h of treatment on DNA
damage index using MCF-7 cells, determined by comet assay.
Control (untreated) or treated cells with TTHL at concentrations IC20,
IC50, and IC80 were used. Data are expressed as mean ± SD of three
independent experiments.derived, with another 8% considered natural product
mimics [33-35]. Anticancer agents from plants currently
in clinical use can be categorized into four main classes
of compounds: vinca (or Catharanthus) alkaloids, epipo-
dophyllotoxins, taxanes, and camptothecins [32].
Alternatively, the pentacyclic triterpenes are a group of
promising secondary plant metabolites for cancer treat-
ment. The triterpenes belonging to the lupane, oleanane
or ursane groups have the potential to treat cancer by
different mechanisms of action [32]. Since Pisha et al.
[36] reported that betulinic acid is a highly promising
anticancer drug, inducing apoptosis in melanoma cellTable 3 Cytotoxicity and antioxidant effect of TTHL
isolated product from ethnolic extract of C. leprosum in S.
cerevisiae
Yeast strains
Treatment WT sod1Δ sod2Δ sod1Δsod2Δ
NCa 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0
TTHL
10 μg/mL
100 ± 2.83 92.60 ± 2.83 83.20 ± 3.68** 79.35 ± 2.19**
TTHL
50 μg/mL
87.65 ± 5.16** 89.30 ± 0.85** 72.90 ± 7.07*** 67.85 ± 10.54***
TTHL
100 μg/mL
79.45 ± 1.91*** 75.65 ± 4.60*** 62.25 ± 3.32*** 58.15 ± 3.89***
TTHL
500 μg/mL
67.65 ± 3.04*** 69.30 ± 3.68*** 56.65 ± 1.06*** 41.45 ± 4.03***
PCb: H2O2
5 mM
63.03 ± 4.12 16.27 ± 4.88 19.10 ± 4.03 19.33 ± 2.10
aNC: negative control (solvent-DMSO). Data significant in relation to negative
control group (solvent) at *P < 0.05, **P < 0.01 and ***P < 0.001/ one-way
ANOVA Tukey’s multiple comparison test. bPositive control (H2O2).
Table 4 Induction of reversion of point mutation for his1-798, ochre allele lys1-1, and frameshift mutation (hom3-10) in
haploid strain XV185-14c of S. cerevisiae after treatment of TTHL isolated product from ethanolic extract of C.
leprosum
Agent Treatment (μg/mL) Survival (%) LYS1/108survivorsb HIS1/107survivorsa HOM3/108survivorsa
STAT cells treated in PBS
NCd 0 100.00 4.00 ± 2.83c 10.50 ± 0.71c 4.0 ± 1.41c
4-NQOe 1.0 μg/mL 39.97*** 20.85 ± 2.48*** 49.50 ± 9.19*** 13.50 ± 4.95**
TTHL 10 μg/mL 84.90 4.78 ± 0.63 10.77 ± 4.40 6.11 ± 1.58
50 μg/mL 72.83 5.68 ± 2.22 13.33 ± 1.10 8.80 ± 0.14
100 μg/mL 65.00 9.72 ± 0.55 20.83 ± 1.80 8.49 ± 2.12
500 μg/mL 69.00 14.40 ± 3.40** 30.10 ± 0.21** 11.15 ± 0.92*
aLocus-specific revertants; bLocus non-specific revertants; cMean and standard deviation per three independent experiments; dNegative control (solvent); ePositive
control; *Data significant in relation to negative control group (solvent) at *P < 0.05; **P < 0.01; ***P < 0.001/ One-way ANOVA-Tukey’s Multiple Comparison Test.
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on the apoptosis-inducing mechanisms.
Accumulating data indicate that the cytotoxic effect of
many chemotherapeutic drugs occurs through pro-
grammed cell death (apoptosis) [37,38]. Hence, the ability
of tumor cells to respond and activate the apoptotic pro-
gram may, in part, determine the success of the therapeutic
strategy [39]. It is well documented that apoptosis can be
induced by a variety of drugs with diverse chemical struc-
tures and different mechanisms of action, and two major
routes including the death-receptor pathway and the
mitochondrial-pathway have been identified [40]. Apoptosis
is a highly regulated process that involves many proteins
and genes [40,41]. It is characterized by cell shrinkage,
plasma membrane bebbling, and chromatin condensation.
The death program is executed by caspases, which amplify
the apoptotic signal and proteolytically process numerous
cellular molecules with different functions [40-42].
Caspases, a family of cysteine proteases, are central
components of cellular apoptosis [41,42]. Based on their
different functions and structures, caspases are classified
into two groups. Caspase-1, −2, −8, −9, and −10 belong to
the first group, called initiator caspases, which can auto-
cleave, and activate the second group of caspases, referred
to as executioner caspases, which include caspase-3, −6,
and −7 [42]. Accumulating evidence reveals that inhibition
of apoptosis cascades plays an important role in tumor
therapy resistance. For example, up-regulation of caspase-
8 inhibitors like Flice-like inhibitory protein or inhibition
of caspase-8 by Bcl-2 can induce tumor resistance to
chemotherapy drugs by decreasing cellular apoptosis
[43]. Suppressing the activation of caspase-9 down-
stream can cause chemotherapy resistance in diffuse
large B-cell lymphoma [44]; overexpression of the in-
hibitor of caspase-3 can activate deoxyribonuclease in
human renal carcinoma cells, therefore enhancing their
resistance to cytotoxic chemotherapy [45]. These stud-
ies strongly suggest that regulating the activity of cas-
pases might be beneficial in tumor chemotherapy.In order to evaluate the new compound TTHL, ob-
tained from C. Leprosum, a folklore medicinal plant, as a
potential therapy for cancer, different concentrations and
exposure times were studied against a panel of six human
tumoral cell lines: MCF-7, HepG2, T24, HCT116, HT29,
CACO-2 (Table 2). We showed that TTHL induces an in-
crease in sub-G1 population (Figure 2), and the induction
of apoptosis by TTHL was confirmed by the increasing
population labeled with Annexin V (Figure 3). We also
observed that there is an increase in the cleavage of
caspase-9, a mediator of the execution phase of apoptosis.
This suggests a mytochondria-mediated triggering of the
apoptotic program in MCF-7 cells that is consistent with
the involvement of oxidative stress (Figure 6 and Table 3).
Here we found that TTHL treatment induced an in-
crease in intracelular ROS formation in MCF-7 cell, as
measured by DCF oxidation (Figure 6). Corroborationg
with these results, TTHL also induced sensitivity in
strains without superoxide dismutase enzyme (Table 3),
which reinforced the indirect action caused by TTHL
through ROS generation in both yeast and mammalian
cells. This suggests that the cellular toxicity of TTHL
must be related with its capacity of TTHL to produce
ROS, and the electrophilicity of TTHL, which enables to
form adducts with cellular macromolecules.
Subsequent experiments focused on direct interaction
of TTHL with DNA. Chemical compounds bearing pla-
nar topologies and electrophilicity are often capable of
intercalating between DNA bases [46]. As TTHL is an
electrophilic molecule with a polar group at either 3-
OH, 6-OH, or 16-OH positions, and was capable of in-
ducing frameshift mutation (Table 4), we suggest TTHL
is a weak intercalator mutagen.
In addition to the mutagenicity assay, the comet assay is
a sensitive and valuable technique to observe genotoxic
damage. The comet assay detects primary (repairable)
single and double-strand DNA breaks and alkali-labile
sites in the alkaline test version. The comet assay results
indicate that TTHL induced DNA strand breaks in MCF-
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gration in comet assay could be explained by either base
damage or strand breaks induction by ROS generation or
by direct action of TTHL on DNA. In this way, the TTHL
DNA-damaging effect occurs not only by ROS generation
but also via DNA intercalation (Table 4).
It is known that various triterpenoids are able to inter-
vene in such processes as DNA repair, cell proliferation,
cell differentiation, angiogenesis and apoptosis [32]. The
antitumoral effects of ursolic acid, maslinic acid and
betulinic acid have been reported to stimulate similar
apoptotic mechanisms. Ursolic acid induces apoptosis
via the mitochondrial intrinsic pathway with alterations
of the Bax/Bcl-2 balance in M4Beu cells [47] and its
anti-carcinogenic properties have also been described
[48]. Several attempts were undertaken for the derivati-
zation of ursolic acid, seeking to obtain analogs with im-
proved anti-tumor activity [32]. Ma et al. [49] modified
the C-3, C-28, C-11 positions of ursolic acid and, among
the 23 derivatives they synthesized, 3β-amino derivative
was found to be 20 times more potent than the parent
ursolic acid in HL-60, Bel-7402 and HeLa cell lines.Figure 7 Schematic representation of the plausible molecular mechan
breast cancer cells. ROS overproduction and DNA intercalaiton lead to DN
mitochondrial pro-death proteins. There is an incresead in the number of c
apoptosis pathway is initiated by lose of mitochondrial potential, which lea
procaspase 9, resulting in activation of initiator caspase 9 and downstreamUsually, compounds with β-oriented hydrogen-bond
forming groups at C-3 exhibit more potent cytotoxicity
than their α-counterparts [32]. Analyzing the structure-
activity relationship (SAR), it appears that a polar group
at either 3-OH, 6-OH, or 16-OH positions is essential
for the cytotoxic activity of TTHL (Figure 1 and Table 1).
Especially, TTHL showed higher activity in antiprolifera-
tion assays in MCF-7 cells.
More recently, some studies have shown that maslinic
acid, a natural pentacyclic triterpene has anti-cancer
capacity in different cell types, including melanoma [50],
liver cancer [51], astrocytoma [52], and colon cancer
[53]. Specifically in colon malignancies, maslinic acid
possesses potent differentiating and anti-proliferation
properties, inducing cell-cycle arrest in the G0/G1 phase
and apoptosis in colon cancer cells without affecting
non-tumoral cells [53].
The induction of apoptosis by betulinic acid involves
several mitochondrial perturbations, such as the release
of cytochrome-c and activation of caspase-8 [54]. Fur-
thermore, it has been reported that the protein Smac is
released during the induction of apoptosis by betulinicism proposed for the induction of apoptosis by TTHL in MCF-7
A damage and mitochondrial dysfunction, resulting in the release of
ells within the sub-G1 phase with a maximum at IC80. The intrinsic
ds to release of cytochrome c. Cytochrome c binds to APAF-1 and
executor caspases.
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down-regulation of Bcl-2, thus blocking the release of
anti-apoptogenic molecules [55]. In addition, the forma-
tion of ROS that modulate Bcl-2 and Bax levels during
the action of betulinic acid has also been detected [56].
Other terpenoids, such as amooranin, induce apoptosis
in MDA-468 cells via the activation of caspases −9, −3,
and −8, the cleavage of Bid and the release of cytochrome-
c from the mitochondria, concomitant with the up-
regulation of p53 and Bax and down-regulation of Bcl-2
[57]. In addition, an increase in the Bax/Bcl-2 ratio and a
decrease in mitochondrial membrane potential have been
reported as being involved in the induction of apoptosis
for alisol B acetate [58].
Conclusions
In this paper the ROS formation by TTHL and its di-
rect interaction with DNA are presented. As indicated
in Figure 7, treating MCF-7 cells with TTHL causes
cascade signaling in the induction of caspases, which
in turn governs the mechanisms for inducing apop-
tosis. Initiator caspase-9 was activated significantly
after 24 h. The apoptotic potency of TTHL suggests
that it may be an effective compound in breast cancer
therapy. Further studies with other biological models
are currently being performed in our laboratory and
should provide a better understanding of the mecha-
nisms underlying these effects.
This is one of the first studies demonstrating the
in vitro antitumor activity of TTHL in MCF-7 cells. The
antitumor effect of TTHL can be further enhanced by
the use of combined therapy and novel drug delivery
systems, thus making it a promising candidate for man-
agement of breast cancer patients.
Additional files
Additional file 1: Figure S8. Cell cycle profile of MCF-7 cells after
24 hours’ treatment with TTHL (IC20, IC50, and IC80) for 24 h. A hypodiploid
peak can be seen in the sub-G1 region. Sub-G1 populations are seen to
appear at both IC50 and IC80. Blue line: control, Red line: IC20, Green line:
IC50, and Pink line: IC80.
Additional file 2: Figure S9. Apoptosis induction in MCF-7 cells.
TTHL-induced apoptosis as shown in the representative example of
Annexin V flow cytometry analysis with the x axis showing Annexin V
staining and the y axis 7-amino-actinomycin D (7-AAD) and phycoerythrin
(PE) staining. The percentage of annexin-V-positive cells was determined in
the whole-cell population (10,000 cells) by FACSCalibur flow cytometry and
CELLQuest software. Percentage of cells in each quadrant, LL: Viable cells
(Annexin V −/ PE −), LR: early apoptotic cells (Annexin V +/ PE −), UL:
necrotic cells (Annexin V −/ PE +) and UR: late apoptotic/necrotic cells
(Annexin V +/ PE +).
Additional file 3: Figure S10. Flow cytometry detection of reactive
oxygen species in MCF-7 cells challenged with TTHL. (A) Representative
histograms: number of cellular events versus fluorescence intensity. FL1-H:
relative DCF fluorescence intensity. Cells were treated with vehicle negative
control, IC20 = 0.50 μg/mL, IC50 = 1.36 μg/mL, and IC80 = 3.70 μg/mL TTHL
after 24 hours’s treatment, and 500 μM H2O2.Competing interests
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